Modulation of dexamphetamine-induced compulsive gnawing--including the possible involvement of presynaptic alpha-adrenoreceptors.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects*; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology*; D004347:Drug Interactions; D010134:Fenclonine / Q000494:pharmacology; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D010276:Parasympatholytics / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D011941:Receptors, Adrenergic / Q000502:physiology*; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D011954:Receptors, Dopamine / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology
D008781:Methyltyrosines; D010276:Parasympatholytics; D010277:Parasympathomimetics; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; D013565:Sympatholytics; D013566:Sympathomimetics; D005406:Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; D012701:Serotonin; D001058:Apomorphine; D010134:Fenclonine; D003913:Dextroamphetamine